Abliva Future Growth
Future criteria checks 0/6
Abliva's revenue and earnings are forecast to decline at 119.9% and 18.8% per annum respectively while EPS is expected to decline by 9.4% per annum.
Key information
-18.8%
Earnings growth rate
-9.4%
EPS growth rate
Biotechs earnings growth | 26.7% |
Revenue growth rate | -119.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Mar 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -160 | -154 | -153 | 1 |
12/31/2024 | N/A | -144 | -140 | -139 | 1 |
12/31/2023 | N/A | -126 | -123 | -122 | 1 |
12/31/2022 | 0 | -85 | -160 | -160 | N/A |
9/30/2022 | 0 | -105 | -195 | -194 | N/A |
6/30/2022 | 0 | -114 | -121 | -120 | N/A |
3/31/2022 | 0 | -124 | -124 | -123 | N/A |
12/31/2021 | 0 | -123 | -115 | -114 | N/A |
9/30/2021 | 2 | -100 | -86 | -84 | N/A |
6/30/2021 | 2 | -75 | -69 | -68 | N/A |
3/31/2021 | 2 | -65 | -54 | -53 | N/A |
12/31/2020 | 2 | -60 | -69 | -68 | N/A |
9/30/2020 | 1 | -74 | -79 | -77 | N/A |
6/30/2020 | 3 | -79 | -84 | -82 | N/A |
3/31/2020 | 4 | -80 | -83 | -80 | N/A |
12/31/2019 | 4 | -77 | -75 | -72 | N/A |
9/30/2019 | 4 | -65 | -67 | -63 | N/A |
6/30/2019 | 2 | -64 | -61 | -57 | N/A |
3/31/2019 | 2 | -69 | -75 | -72 | N/A |
12/31/2018 | 2 | -68 | -68 | -64 | N/A |
9/30/2018 | 2 | -68 | -66 | -62 | N/A |
6/30/2018 | 2 | -66 | -68 | -64 | N/A |
3/31/2018 | 0 | -63 | -61 | -57 | N/A |
12/31/2017 | 0 | -67 | -62 | -58 | N/A |
9/30/2017 | 0 | -66 | -72 | -60 | N/A |
6/30/2017 | 0 | -87 | -69 | -55 | N/A |
3/31/2017 | 0 | -76 | -73 | -55 | N/A |
12/31/2016 | 0 | -70 | -76 | -57 | N/A |
9/30/2016 | N/A | -63 | N/A | -62 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABLIS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ABLIS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ABLIS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ABLIS is forecast to have no revenue next year.
High Growth Revenue: ABLIS is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ABLIS's Return on Equity is forecast to be high in 3 years time